Galectin-1 as a potential diagnostic biomarker in polycystic ovary syndrome.

Eur Rev Med Pharmacol Sci

Department of Obstetrics and Gynecology, Department of Biochemistry, Department of Biostatistics, Faculty of Medicine, Malatya Turgut Özal University, Malatya, Turkey.

Published: March 2023

AI Article Synopsis

Article Abstract

Objective: This study was aimed at comparing the routine laboratory parameters and Galectin-1 levels of control and polycystic ovarian syndrome patients.

Patients And Methods: 88 patients diagnosed with polycystic ovary syndrome and 88 healthy controls were considered for the study. Age groups of the patients ranged from 18 to 40. Serum TSH, Beta HCG, glucose, insulin, HOMA-IR, Hb1A1c, triglyceride, total cholesterol, LDL FSH, LH, E2, prolactin, testosterone, SHBG, DHESO4, HDL, Gal-1 levels were analyzed for each subject.

Results: FSH, LH, LH/FSH, E2, prolactin, testosterone, SHBG, DHESO4, HDL and Gal-1 values of the subjects included in the study were statistically significantly different between the groups (p<0.05). Gal-1 and DHESO4 showed a strong positive connection (p=0.05). The sensitivity of Gal-1 level in PCOS patients was calculated as 0.997 and specificity as 0.716.

Conclusions: High levels of Gal-1 in PCOS patients suggest that it increases due to overexpression in response to inflammation.

Download full-text PDF

Source
http://dx.doi.org/10.26355/eurrev_202303_31788DOI Listing

Publication Analysis

Top Keywords

polycystic ovary
8
ovary syndrome
8
prolactin testosterone
8
testosterone shbg
8
shbg dheso4
8
dheso4 hdl
8
hdl gal-1
8
galectin-1 potential
4
potential diagnostic
4
diagnostic biomarker
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!